Literature DB >> 15245810

Handling and pathology reporting of prostate biopsies.

Liliane Boccon-Gibod1, Th H van der Kwast, Rodolfo Montironi, Laurent Boccon-Gibod, Aldo Bono.   

Abstract

Appropriate handling and processing of prostate needle biopsies is critical for an optimal examination by pathologists. Reporting by pathologists should be accurate, unequivocal and concise, giving the information needed for the urologist. Quality parameters need to be developed to survey the performance of pathology laboratories.

Mesh：

Year:  2004        PMID： 15245810     DOI： 10.1016/j.eururo.2004.04.006

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  18 in total

Review 1.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 2.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

3.  Minimum 6 mm core length is strongly predictive for the presence of glandular tissue in transrectal prostate biopsy.

Authors:  Hasan Yilmaz; Seyfettin Ciftci; Murat Ustuner; Ufuk Yavuz; Ali Saribacak; Bahar Muezzinoglu; Ozdal Dillioglugil
Journal:  World J Urol       Date:  2015-03-17       Impact factor: 4.226

4.  Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria.

Authors:  G I Russo; T Castelli; V Favilla; G Reale; D Urzì; S Privitera; E Fragalà; S Cimino; G Morgia
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-06-02       Impact factor: 5.554

5.  Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011.

Authors:  Deepak A Kapoor; David G Bostwick; Savvas E Mendrinos; Ann E Anderson; Carl A Olsson
Journal:  Rev Urol       Date:  2013

6.  Does length of prostate biopsy cores have an impact on diagnosis of prostate cancer?

Authors:  Müslüm Ergün; Ekrem İslamoğlu; Soner Yalçınkaya; Hüsnü Tokgöz; Murat Savaş
Journal:  Turk J Urol       Date:  2016-09

7.  Do longer or shorter cores yield more cancer?

Authors:  Yılmaz Hasan; Dillioğlugil Özdal
Journal:  World J Urol       Date:  2018-04-27       Impact factor: 4.226

8.  Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.

Authors:  Hasan Yılmaz; Ufuk Yavuz; Murat Üstüner; Seyfettin Çiftçi; Hikmet Yaşar; Bahar Müezzinoğlu; Ali Kemal Uslubaş; Özdal Dillioğlugil
Journal:  Turk J Urol       Date:  2017-07-31

9.  High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance.

Authors:  Guillaume Ploussard; Gwendoline Plennevaux; Yves Allory; Laurent Salomon; Sandy Azoulay; Dimitri Vordos; Andreas Hoznek; Claude-Clément Abbou; Alexandre de la Taille
Journal:  World J Urol       Date:  2009-04-17       Impact factor: 4.226

10.  Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  T Van der Kwast; L Bubendorf; C Mazerolles; M R Raspollini; G J Van Leenders; C-G Pihl; P Kujala
Journal:  Virchows Arch       Date:  2013-08-06       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.